Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

BUY
$6.09 - $7.93 $107,793 - $140,361
17,700 New
17,700 $0
Q1 2022

May 13, 2022

SELL
$21.6 - $27.79 $205,200 - $264,005
-9,500 Closed
0 $0
Q4 2021

Jan 26, 2022

SELL
$23.0 - $29.01 $62,100 - $78,327
-2,700 Reduced 22.13%
9,500 $262,000
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $55,088 - $66,132
-2,200 Reduced 15.28%
12,200 $340,000
Q2 2021

Aug 12, 2021

BUY
$27.43 - $32.7 $2,743 - $3,270
100 Added 0.7%
14,400 $422,000
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $51,288 - $82,512
-2,400 Reduced 14.37%
14,300 $454,000
Q4 2020

Feb 16, 2021

BUY
$15.31 - $21.12 $68,895 - $95,040
4,500 Added 36.89%
16,700 $347,000
Q3 2020

Nov 09, 2020

BUY
$14.88 - $20.13 $181,536 - $245,586
12,200 New
12,200 $190,000
Q2 2020

Aug 07, 2020

SELL
$13.31 - $20.51 $161,051 - $248,171
-12,100 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$12.98 - $30.25 $7,788 - $18,150
-600 Reduced 4.72%
12,100 $188,000
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $96,339 - $162,639
-5,100 Reduced 28.65%
12,700 $380,000
Q3 2019

Oct 29, 2019

BUY
$20.88 - $25.66 $12,528 - $15,396
600 Added 3.49%
17,800 $389,000
Q2 2019

Jul 25, 2019

BUY
$20.52 - $26.45 $28,728 - $37,030
1,400 Added 8.86%
17,200 $434,000
Q1 2019

Apr 25, 2019

SELL
$20.23 - $26.29 $12,138 - $15,774
-600 Reduced 3.66%
15,800 $390,000
Q4 2018

Feb 04, 2019

SELL
$17.64 - $28.32 $109,368 - $175,584
-6,200 Reduced 27.43%
16,400 $303,000
Q3 2018

Oct 23, 2018

BUY
$20.64 - $25.67 $466,464 - $580,142
22,600 New
22,600 $580,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.